Tag: Bevacizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Bevacizumab

With a forecasted CAGR of 13.9%, the Cancer Monoclonal Antibodies market size is set to ...

Added to Collection on: 2023-09-15 18:17:08

Tags for this article:

Immunology
Monoclonal antibodies
Biotechnology
Immune system
Humanized antibody
Bevacizumab
Ipilimumab
Passive antibody therapy
Monoclonal antibody therapy

Click the tags to see associated articles and topics

View Article Details
Olaparib by AstraZeneca for Diffuse Large B-Cell Lymphoma: Likelihood of Approval

Added to Collection on: 2023-10-27 23:15:17

Tags for this article:

Orphan drugs
PARP inhibitors
Gynaecological cancer
Infectious causes of cancer
Breakthrough therapy
Olaparib
Bevacizumab
Ovarian cancer
Cancer
Breast cancer
Triple-negative breast cancer
Non-small-cell lung cancer

Click the tags to see associated articles and topics

View Article Details
HealthLingo: Biologic and Biosimilar

Added to Collection on: 2023-11-06 22:08:34

Tags for this article:

Biotechnology
Specialty drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
TNF inhibitors
Biopharmaceutical
Biosimilar
Adalimumab
Food and Drug Administration
Rheumatoid arthritis
Bevacizumab
Etanercept

Click the tags to see associated articles and topics

View Article Details
Innovent's MSCI ESG Rating Upgraded to A - PR Newswire

Added to Collection on: 2023-11-30 23:58:46

Tags for this article:

Biotechnology
Specialty drugs
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
MSCI
Incyte
Pharmaceutical industry in India
Bevacizumab
Yu Dechao
Research LLC
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Atezolizumab by F. Hoffmann-La Roche for Colorectal Cancer: Likelihood of Approval

Added to Collection on: 2023-12-25 18:21:40

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Atezolizumab
Carcinoma
Infectious causes of cancer
Bevacizumab
Non-small-cell lung cancer
Small-cell carcinoma
Targeted therapy
Transitional cell carcinoma
Anaplastic lymphoma kinase
F. Hoffmann-La Roche
HOFFMANN - LA ROCHE

Click the tags to see associated articles and topics

View Article Details
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical Cancer

Added to Collection on: 2024-01-06 04:39:44

Tags for this article:

Orphan drugs
Atezolizumab
Bevacizumab
Survival rate
TIGIT
Durvalumab

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Imfinzi combination shows promise in phase 3 liver cancer study - PMLiVE

Added to Collection on: 2024-01-23 13:43:45

Tags for this article:

Orphan drugs
Hepatology
Monoclonal antibodies
Infectious causes of cancer
Durvalumab
Hepatocellular carcinoma
Progression-free survival
Liver cancer
Tremelimumab
Bevacizumab
Clinical endpoint
Bland embolization
Avastin
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Innovent Announces Retirement of CFO and Appointment of New CFO - Yahoo Finance

Added to Collection on: 2024-02-05 18:34:47

Tags for this article:

Specialty drugs
Orphan drugs
Monoclonal antibodies
Angiogenesis inhibitors
Cancer immunotherapy
Sintilimab
Eli Lilly and Company
Biosimilar
Biopharmaceutical
Incyte
Adalimumab
Bevacizumab
Innovent Biologics Inc.

Click the tags to see associated articles and topics

View Article Details
Global Bevacizumab Biosimilars Market Outlook 2024-2028 & - GlobeNewswire

Added to Collection on: 2024-03-07 00:29:10

Tags for this article:

Specialty drugs
Biopharmaceuticals
Biosimilar
Biotechnology
Biotechnology products
Bevacizumab
Biocon
Viatris
Pharmaceutical industry in India
Intas Pharmaceuticals
Amneal Pharmaceuticals
Aurobindo Pharma

Click the tags to see associated articles and topics

View Article Details
Dr. Goswami's Oncology Journey: Patient-centric Science and Mentorship Stories - OncLive

Added to Collection on: 2024-04-15 19:20:50

Tags for this article:

Orphan drugs
Piperazines
Fluoroarenes
Pyridines
Antineoplastic drugs
Cetuximab
KRAS
Bevacizumab
Regorafenib
Adagrasib
Ponatinib
Radiation therapy

Click the tags to see associated articles and topics

View Article Details